Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MEDIFAST INC (MED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: MED (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $15
1 Year Target Price $15
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -34.05% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 153.55M USD | Price to earnings Ratio 42.33 | 1Y Target Price 15 |
Price to earnings Ratio 42.33 | 1Y Target Price 15 | ||
Volume (30-day avg) 1 | Beta 0.84 | 52 Weeks Range 11.57 - 21.98 | Updated Date 09/14/2025 |
52 Weeks Range 11.57 - 21.98 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.76% | Operating Margin (TTM) -1.01% |
Management Effectiveness
Return on Assets (TTM) 2.88% | Return on Equity (TTM) 1.73% |
Valuation
Trailing PE 42.33 | Forward PE - | Enterprise Value 3940164 | Price to Sales(TTM) 0.32 |
Enterprise Value 3940164 | Price to Sales(TTM) 0.32 | ||
Enterprise Value to Revenue 0.01 | Enterprise Value to EBITDA 0.28 | Shares Outstanding 10991100 | Shares Floating 9146450 |
Shares Outstanding 10991100 | Shares Floating 9146450 | ||
Percent Insiders 3.2 | Percent Institutions 80.11 |
Upturn AI SWOT
MEDIFAST INC
Company Overview
History and Background
Medifast, Inc. was founded in 1980. It began as a formula developed by a physician for Johns Hopkins University for obese patients. It has evolved from direct sales and medical channels to include a multi-level marketing model with health coaches.
Core Business Areas
- OPTAVIA: OPTAVIA is Medifast's primary business segment. It involves a comprehensive program for weight loss and health management, utilizing a network of independent OPTAVIA Coaches who guide and support clients through their journey.
Leadership and Structure
Daniel R. Chard is the Chairman and CEO. The company is structured with executive leadership overseeing finance, marketing, operations, and technology.
Top Products and Market Share
Key Offerings
- OPTAVIA Program and Products: OPTAVIA is a structured weight loss program using meal replacements (Fuelings) and lean and green meals, supported by health coaches. No precise market share data is available, but Medifast operates in the weight management industry, competing with companies like WW International, Herbalife, and Nutrisystem. The market for weight management and nutrition is estimated in the billions.
Market Dynamics
Industry Overview
The weight management industry is characterized by shifting consumer preferences, growing concerns about obesity and health, and increased competition from various diet programs, supplements, and fitness solutions. Online and digital health services are also gaining prominence.
Positioning
Medifast positions itself as a provider of comprehensive weight loss solutions with a focus on community support through its OPTAVIA coaching network. Its competitive advantage lies in its structured program and personalized coaching approach.
Total Addressable Market (TAM)
The global weight management market is estimated to be worth over $100 billion. Medifast is positioned to capture a portion of this TAM through its OPTAVIA program, focusing on personalized coaching and structured plans.
Upturn SWOT Analysis
Strengths
- Strong OPTAVIA coaching network
- Structured and proven weight loss program
- Brand recognition in the weight management sector
- Subscription-based revenue model
Weaknesses
- Reliance on OPTAVIA coach recruitment and retention
- Potential for negative publicity related to MLM practices
- Sensitivity to economic downturns (discretionary spending)
- High marketing expenses
Opportunities
- Expansion into new geographic markets
- Development of new products and services within the OPTAVIA ecosystem
- Increased focus on digital health and telehealth solutions
- Partnerships with healthcare providers and corporate wellness programs
Threats
- Intense competition in the weight management industry
- Changes in consumer preferences and diet trends
- Regulatory scrutiny of MLM business models
- Economic downturns affecting consumer spending
Competitors and Market Share
Key Competitors
- WW
- HLF
- NUTR
Competitive Landscape
Medifast differentiates itself through its OPTAVIA coaching network, providing personalized support. WW focuses on lifestyle changes and community, while Herbalife relies on a distributor network. Nutrisystem offers pre-packaged meals.
Growth Trajectory and Initiatives
Historical Growth: Historical Growth unavailable, this is based on hypothetical data. Medifast has experienced revenue growth in recent years, driven by the expansion of its OPTAVIA coaching network.
Future Projections: Future Projections unavailable, this is based on hypothetical data. Analyst estimates vary but generally project continued growth, contingent on coach recruitment and retention.
Recent Initiatives: Recent Initiatives include enhancements to the OPTAVIA program, expansion of product offerings, and investments in technology to support the coaching network.
Summary
Medifast demonstrates strength in its OPTAVIA coaching program and structured approach. Its reliance on coach recruitment poses a risk, and competition within the weight management sector is intense. Future success depends on market expansion and innovative product development. Regulatory scrutiny of MLM practices remain a key challenge.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, market research reports, analyst estimates, historical SEC filings
Disclaimers:
This analysis is based on available data and analyst estimates, which are subject to change. The AI-based rating is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MEDIFAST INC
Exchange NYSE | Headquaters Baltimore, MD, United States | ||
IPO Launch date 1993-12-31 | Executive Chairman & CEO Mr. Daniel R. Chard | ||
Sector Consumer Cyclical | Industry Personal Services | Full time employees 504 | Website https://medifastinc.com |
Full time employees 504 | Website https://medifastinc.com | ||
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.